Delivery Order SPE2DR25D3301-SPE2DR26F21GA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,764.80 to AmerisourceBergen Drug Corp for the supply of Rectiv 0.4% Ointment on January 7, 2026, with an ultimate completion date of February 4, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,378.12 to AmerisourceBergen Drug Corp for the supply of Rectiv 0.4% Ointment in 30-gram units. This competitively awarded, firm fixed-price delivery order was issued on January 13, 2026, with an ultimate completion date of January 14, 2026. The contract involves no set-aside designation, allowing the award to be made through full and open competition. The place of performance is listed as Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Rectiv 0.4% Ointment in 30-gram units. This firm fixed-price delivery order, valued at $2,833.45, was competitively awarded without a set-aside designation and carries an ultimate completion date of September 17, 2025. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for Rectiv 0.4% Ointment (30 grams) with a ceiling value of approximately $4.0K under a firm fixed-price contract. The award, dated November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-set-aside competitive award to the prime contractor. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rectiv 0.4% Ointment in 30-gram quantities under a firm fixed-price contract with a ceiling value of $3,960.82. The award was issued on December 8, 2025, with an ultimate completion date of December 9, 2025, and involved no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed this delivery order from its Corporate Office division,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for Rectiv 0.4% Ointment in 30-gram quantities, with a ceiling value of $3,515.21. This firm fixed-price delivery order, which will be completed by May 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will occur at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,219.76 to AmerisourceBergen Drug Corp for Rectiv 0.4% Ointment in a 30-gram quantity. The contract was competitively awarded without a set-aside designation and utilizes firm fixed pricing. This delivery order was completed on April 23, 2025, one day after the award date of April 22, 2025. The product will be performed and sourced from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Rectiv 0.4% Ointment in 30-gram units, with a firm fixed price ceiling value of $1,570.88 and an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram quantities, with a ceiling value of $2,518.06 and an ultimate completion date of September 5, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Rectiv 0.4% Ointment in 30-gram units, with a ceiling value of $2,889.81. The contract was awarded on August 28, 2025, under a firm fixed-price delivery order structure with an ultimate completion date of August 29, 2025. This award utilizes no set-aside designation and represents a competitively awarded transaction through the company's existing contract vehicle. The place of...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F21GADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,594.77 to AmerisourceBergen Drug Corp for Rectiv 0.4% Ointment in a 30-gram formulation on January 26, 2026, with an ultimate completion date of January 27, 2026. This firm fixed-price delivery order was awarded on a non-competitive basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal healthcare needs, particularly for military and veteran systems. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains. The contract demonstrates the contractor's capability to fulfill federal medical supply requirements through the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/25/26 |